Fatih Yiğit

Fatih Yiğit

Auto-generated profile, based on publicly available information

Fatih Yiğit

Department of Cardiovascular Surgery, University of Health Sciences, Koşuyolu High Specialty and Research Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in The European Research Journal
Verified
Journal Article
Open access
PDF file
EAErgi̇n Arslanoglu
Ergi̇n Arslanoglu
KKKenan Abdurrahman Kara
Kenan Abdurrahman Kara
SBShiraslan Bakhshaliyev
Shiraslan Bakhshaliyev
FYFatih Yiğit
Fatih Yiğit
DTDoğan Çağrı Tanrıverdi
Doğan Çağrı Tanrıverdi
HCHakan Ceyran
Hakan Ceyran
Objectives: Transposition of the great arteries (TGA) is a rare congenital heart disease that occurs in 3 in 10,000 newborns and is rapidly fatal (90%) within one year if left untreated. The prognosis of this pathology changed after introducing an early arterial switch operation (ASO), while the left ventricle could still adapt to systemic high-pressure conditions. Appropriate regulation of thyroid hormones positively impacts metabolism, cardiac function, and postoperative recovery. Therefore, regular thyroid hormone monitoring and thyroid function monitoring of TGA patients may help to improve the health status and prognosis of this group of postoperative patients. Methods: In our study, 127 patients who underwent ASO at our pediatric cardiac surgery clinic between 01.01.2014 and 18.09.2021 were retrospectively analyzed and included. Among the patients, 43% (n=54) were females, and 57% (n=73) were males. Results: The coronary arteries were normal in 89.7% (n=114) and abnormal in 10.3% (n=13) of the patients. Twenty-one of the patients exited, and mortality was calculated to be 16.5%. There were no significant differences in mortality or thyroid stimulating hormone (TSH), free thyroxine (T4), or free triiodothyronine (T3) values (P=0.674, P=0.345, P=0.478). In our study, in which we investigated the effect of thyroid hormone levels on prognosis in neonatal patients with TGA with normal free T3, T4, and TSH values, we found that TSH levels were greater in the group with advanced aortic regurgitation and exitus, although the effect of thyroid hormones on postoperative results was not statistically significant. Conclusions: Congenital hypothyroidism is a common disease with cardiac effects. During the neonatal period, this disease may conceal itself. Careful, expert clinical follow-up and clinical trials are crucial to improve outcomes in the surgical treatment of transposition of the great arteries, a complex congenital heart disease.

1 December 2025 in Kosuyolu Heart Journal
Verified
Journal Article
Open access
PDF file
SBShiraslan Bakhshaliyev
Shiraslan Bakhshaliyev
EAErgi̇n Arslanoglu
Ergi̇n Arslanoglu
BABahruz Aliyev
Bahruz Aliyev
FYFatih Yiğit
Fatih Yiğit
Objectives: Low cardiac output syndrome (LCOS) is a critical complication following pediatric cardiac surgery that is characterized by myocardial dysfunction, hemodynamic instability, and insufficient organ perfusion. Levosimendan, an inotropic agent that enhances calcium sensitivity in cardiac muscle and causes vasodilation, has been proposed as a therapeutic option for managing LCOS in children. This study aimed to evaluate the efficacy and safety of levosimendan in the 23 management of LCOS in pediatric patients following cardiac surgery. Methods: This study retrospectively included patients who underwent surgery in our clinic between 2020 and 2023 and received levosimendan due to post-operative LCOS. The patients’ medical records were accessed through the hospital information system and archival review. Results: The median age of the patients was 8 months (interquartile range: 5.0–16.0 months). Post-operative echocardiographic assessments revealed a significant improvement in ejection fraction, with a median increase from 40.0% to 57.5% in survivors (p<0.001). No significant difference in mortality, intensive care unit stay, or hospital stay was observed between survivors and non-survivors, although non-survivors had a higher post-operative heart rate (p=0.025). Levosimendan was well tolerated, with minimal adverse effects, and no arrhythmias were recorded. Hypotension was effectively managed with norepinephrine. Conclusion: Levosimendan appears to be an effective and safe treatment option for managing LCOS in pediatric patients after cardiac surgery. While the drug significantly improved cardiac function, further large-scale studies are necessary to evaluate its long-term efficacy and safety. Individualized dosing and careful monitoring are essential to optimize patient outcomes.